FDA Approved: DICLOFENAC SODIUM — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for diclofenac sodium topical gel 1% from BluePoint Laboratories, authorizing its marketing as a generic NSAID topical g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• diclofenac sodium topical gel, 1% (diclofenac sodium topical gel, 1%)

Snippet

SUPPL AP for DICLOFENAC SODIUM (DICLOFENAC SODIUM TOPICAL GEL, 1%)